Global Nuclear Medicine/Radiopharmaceutic Market has been getting lots of traction from different emerging countries and regions and in the times of COVID-19, the market is expected to change % in terms of year on year growth. To study the impact of COVID-19, the research has been segmented by Type, By Application, By Regions and By Companies. The report will shed light on very important growth aspect of Nuclear Medicine/Radiopharmaceutic and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
Nuclear Medicine/Radiopharmaceutic Market Analysis By Type Segment:
Diagnostic
Therapeutic
Key data provided:
Market Size By Application
Market Share By Application
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Price (If Available)
Nuclear Medicine/Radiopharmaceutic Market Analysis By Application Segment:
Oncology
Thyroid
Cardiology
Others
Key data provided:
Market Size By Application
Market Share By Application
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Nuclear Medicine/Radiopharmaceutic Market Analysis By Regions (Countries):-
The Nuclear Medicine/Radiopharmaceutic Market has been thoroughly researched with help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the regions i.e. North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Nuclear Medicine/Radiopharmaceutic Report:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Key data provided:
Market Size By Regions and Countries
Market Share By Regions and Countries
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Nuclear Medicine/Radiopharmaceutic Market:
Nuclear Medicine/Radiopharmaceutic market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The major vendors covered:
China Isotope Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Cardinal Health
Mallinckrodt
GE Healthcare
Lantheus Medical Imaging
Bayer Healthcare
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications
Iba Molecular Imaging
The study objectives are:
To analyze and research the Nuclear Medicine/Radiopharmaceutic Market status and future forecast in North America, Europe, APAC and MEA involving value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Nuclear Medicine/Radiopharmaceutic Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Available Customizations in The Report:
We can add additional companies as per your choice in the report
We can add specific country/countries of your choice
We can add additional segments such as market by technology, raw material, distribution channel, platform etc.*
Investment Analysis in specific country
We can source details of suppliers and distributors for potential collaboration
* Data is subject to availability
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Type (2020-2027)
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Market Segment by Application
1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Share by Application (2020-2027)
1.4.2 Oncology
1.4.3 Thyroid
1.4.4 Cardiology
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size
2.1.1 Global Nuclear Medicine/Radiopharmaceutic Revenue 2016-2027
2.1.2 Global Nuclear Medicine/Radiopharmaceutic Sales 2016-2027
2.2 Nuclear Medicine/Radiopharmaceutic Growth Rate by Regions
2.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Regions 2016-2020
2.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions 2016-2020
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers
3.1.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers 2016-2020
3.1.2 Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturers 2016-2020
3.2 Revenue by Manufacturers
3.2.1 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2016-2020)
3.2.2 Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2016-2020)
3.2.3 Global Nuclear Medicine/Radiopharmaceutic Market Concentration Ratio (CR5 and HHI)
3.3 Nuclear Medicine/Radiopharmaceutic Price by Manufacturers
3.4 Key Manufacturers Nuclear Medicine/Radiopharmaceutic Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
3.6 Key Manufacturers Nuclear Medicine/Radiopharmaceutic Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Diagnostic Sales and Revenue (2016-2020)
4.1.2 Therapeutic Sales and Revenue (2016-2020)
4.2 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type
4.3 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type
4.4 Nuclear Medicine/Radiopharmaceutic Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Nuclear Medicine/Radiopharmaceutic Sales by Application
6 United States
6.1 United States Nuclear Medicine/Radiopharmaceutic Breakdown Data by Company
6.2 United States Nuclear Medicine/Radiopharmaceutic Breakdown Data by Type
6.3 United States Nuclear Medicine/Radiopharmaceutic Breakdown Data by Application
7 European Union
7.1 European Union Nuclear Medicine/Radiopharmaceutic Breakdown Data by Company
7.2 European Union Nuclear Medicine/Radiopharmaceutic Breakdown Data by Type
7.3 European Union Nuclear Medicine/Radiopharmaceutic Breakdown Data by Application
8 China
8.1 China Nuclear Medicine/Radiopharmaceutic Breakdown Data by Company
8.2 China Nuclear Medicine/Radiopharmaceutic Breakdown Data by Type
8.3 China Nuclear Medicine/Radiopharmaceutic Breakdown Data by Application
9 Rest of World
9.1 Rest of World Nuclear Medicine/Radiopharmaceutic Breakdown Data by Company
9.2 Rest of World Nuclear Medicine/Radiopharmaceutic Breakdown Data by Type
9.3 Rest of World Nuclear Medicine/Radiopharmaceutic Breakdown Data by Application
9.4 Rest of World Nuclear Medicine/Radiopharmaceutic Breakdown Data by Countries
9.4.1 Rest of World Nuclear Medicine/Radiopharmaceutic Sales by Countries
9.4.2 Rest of World Nuclear Medicine/Radiopharmaceutic Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 China Isotope Radiation
10.1.1 China Isotope Radiation Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
10.1.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
10.1.5 China Isotope Radiation Recent Development
10.2 Dongcheng
10.2.1 Dongcheng Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
10.2.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
10.2.5 Dongcheng Recent Development
10.3 Jaco
10.3.1 Jaco Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
10.3.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
10.3.5 Jaco Recent Development
10.4 Ciaeriar
10.4.1 Ciaeriar Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
10.4.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
10.4.5 Ciaeriar Recent Development
10.5 Advanced Molecular-imaging Solution
10.5.1 Advanced Molecular-imaging Solution Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
10.5.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
10.5.5 Advanced Molecular-imaging Solution Recent Development
10.6 Shanghai Atom Kexing
10.6.1 Shanghai Atom Kexing Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
10.6.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
10.6.5 Shanghai Atom Kexing Recent Development
10.7 Cardinal Health
10.7.1 Cardinal Health Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
10.7.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
10.7.5 Cardinal Health Recent Development
10.8 Mallinckrodt
10.8.1 Mallinckrodt Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
10.8.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
10.8.5 Mallinckrodt Recent Development
10.9 GE Healthcare
10.9.1 GE Healthcare Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
10.9.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
10.9.5 GE Healthcare Recent Development
10.10 Lantheus Medical Imaging
10.10.1 Lantheus Medical Imaging Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
10.10.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
10.10.5 Lantheus Medical Imaging Recent Development
10.11 Bayer Healthcare
10.12 Bracco Imaging
10.13 Eczacibasi-Monrol Nuclear Products
10.14 Nordion
10.15 Advanced Accelerator Applications
10.16 Iba Molecular Imaging
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Nuclear Medicine/Radiopharmaceutic Sales Channels
11.2.2 Nuclear Medicine/Radiopharmaceutic Distributors
11.3 Nuclear Medicine/Radiopharmaceutic Customers
12 Market Forecast
12.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Revenue Forecast 2020-2027
12.2 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type
12.3 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application
12.4 Nuclear Medicine/Radiopharmaceutic Forecast by Regions
12.4.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions 2020-2027
12.4.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Regions 2020-2027
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Nuclear Medicine/Radiopharmaceutic Product Picture
Table Nuclear Medicine/Radiopharmaceutic Key Market Segments
Table Major Manufacturers Nuclear Medicine/Radiopharmaceutic Covered in This Report
Table Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Type 2020-2027(MT) & (Million US$)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Shar by Type 2016-2027
Figure Diagnostic Figures
Table Major Manufacturers of Diagnostic
Figure Therapeutic Figures
Table Major Manufacturers of Therapeutic
Table Global Nuclear Medicine/Radiopharmaceutic Market Share by Application 2020-2027(MT)
Figure Oncology Use Case
Figure Thyroid Use Case
Figure Cardiology Use Case
Figure Others Use Case
Figure Nuclear Medicine/Radiopharmaceutic Report Years Considered
Figure Global Nuclear Medicine/Radiopharmaceutic Market Size 2016-2027 (Million US$)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales 2016-2020 (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Market Size by Regions 2016-2020 (MT) & (Million US$)
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Regions 2016-2020 (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions 2016-2020
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions 2016-2020
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions in 2020
Table Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions 2016-2020 (Million US$)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions 2016-2020
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions 2016-2020
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions in 2020
Table Market Top Trends
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers (2016-2020) (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturers (2016-2020)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturers in 2020
Table Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2016-2020) (Million USD)
Table Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2016-2020)
Figure Nuclear Medicine/Radiopharmaceutic Value Share by Manufacturers in 2020
Table Global Nuclear Medicine/Radiopharmaceutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Nuclear Medicine/Radiopharmaceutic Price (2016-2020) (USD/Kg)
Table Key Manufacturers Nuclear Medicine/Radiopharmaceutic Plants/Factories Distribution
Table Key Manufacturers Nuclear Medicine/Radiopharmaceutic Area Served
Table Date of Key Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
Table Key Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Diagnostic Sales and Revenue (2016-2020) (MT) & (Million US$)
Table Global Therapeutic Sales and Revenue (2016-2020) (MT) & (Million US$)
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2020) (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2016-2020)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2020)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2020
Table Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2016-2020) (Million US$)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2016-2020)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type (2016-2020)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type in 2020
Table Nuclear Medicine/Radiopharmaceutic Price by Type 2016-2020 (USD/Kg)
Table Global Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2020) (MT)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2016-2020)
Figure Global Sales Nuclear Medicine/Radiopharmaceutic Market Share by Application (2016-2020)
Figure Global Sales Nuclear Medicine/Radiopharmaceutic Market Share by Application (2016-2020)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2016-2020 (MT)
Figure United States Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2016-2020 (Million US$)
Table United States Nuclear Medicine/Radiopharmaceutic Sales by Company (2016-2020) (MT)
Table United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2016-2020)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company in 2020
Table United States Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2020) (MT)
Table United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2020)
Figure United States Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2020
Table United States Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2020) (MT)
Table United States Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2020)
Figure United States Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2020
Figure European Union Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2016-2020 (MT)
Figure European Union Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2016-2020 (Million US$)
Table European Union Nuclear Medicine/Radiopharmaceutic Sales by Company (2016-2020) (MT)
Table European Union Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2016-2020)
Figure European Union Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company in 2020
Table European Union Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2020) (MT)
Table European Union Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2020)
Figure 2020 European Union Nuclear Medicine/Radiopharmaceutic Market Share by Type
Table European Union Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2020) (MT)
Table European Union Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2020)
Figure 2020 European Union Nuclear Medicine/Radiopharmaceutic Market Share by Application
Figure China Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2016-2020 (MT)
Figure China Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2016-2020 (Million US$)
Table China Nuclear Medicine/Radiopharmaceutic Sales by Company (2016-2020) (MT)
Table China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2016-2020)
Figure China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company in 2020
Table China Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2020) (MT)
Table China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2020)
Figure China Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2020
Table China Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2020) (MT)
Table China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2020)
Figure China Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2020
Figure Rest of World Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2016-2020 (MT)
Figure Rest of World Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2016-2020 (Million US$)
Table Rest of World Nuclear Medicine/Radiopharmaceutic Sales by Company (2016-2020) (MT)
Table Rest of World Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2016-2020)
Figure Rest of World Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company in 2020
Table Rest of World Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2020) (MT)
Table Rest of World Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2020)
Figure Rest of World Nuclear Medicine/Radiopharmaceutic Market Share by Type in 2020
Table Rest of World Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2020) (MT)
Table Rest of World Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2020)
Figure Rest of World Nuclear Medicine/Radiopharmaceutic Market Share by Application in 2020
Table Rest of World Nuclear Medicine/Radiopharmaceutic Sales by Countries (2016-2020) (MT)
Table Rest of World Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2016-2020)
Figure Rest of World Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries in 2020
Table Rest of World Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2016-2020) (Million US$)
Table Rest of World Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2016-2020)
Figure Rest of World Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries in 2020
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2020) (MT)
Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2020) (MT)
Figure Korea Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2020) (MT)
Figure Korea Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2020) (MT)
Figure India Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2020) (MT)
Figure India Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2020) (MT)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2020) (MT)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2020) (MT)
Table China Isotope Radiation Company Details
Table China Isotope Radiation Description and Business Overview
Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2020)
Table China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales Market Share in Global Market
Table China Isotope Radiation Recent Development
Table Dongcheng Company Details
Table Dongcheng Description and Business Overview
Table Dongcheng Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Dongcheng Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2020)
Table Dongcheng Nuclear Medicine/Radiopharmaceutic Sales Market Share in Global Market
Table Dongcheng Recent Development
Table Jaco Company Details
Table Jaco Description and Business Overview
Table Jaco Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Jaco Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2020)
Table Jaco Nuclear Medicine/Radiopharmaceutic Sales Market Share in Global Market
Table Jaco Recent Development
Table Ciaeriar Company Details
Table Ciaeriar Description and Business Overview
Table Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2020)
Table Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales Market Share in Global Market
Table Ciaeriar Recent Development
Table Advanced Molecular-imaging Solution Company Details
Table Advanced Molecular-imaging Solution Description and Business Overview
Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2020)
Table Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales Market Share in Global Market
Table Advanced Molecular-imaging Solution Recent Development
Table Shanghai Atom Kexing Company Details
Table Shanghai Atom Kexing Description and Business Overview
Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2020)
Table Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales Market Share in Global Market
Table Shanghai Atom Kexing Recent Development
Table Cardinal Health Company Details
Table Cardinal Health Description and Business Overview
Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2020)
Table Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales Market Share in Global Market
Table Cardinal Health Recent Development
Table Mallinckrodt Company Details
Table Mallinckrodt Description and Business Overview
Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2020)
Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales Market Share in Global Market
Table Mallinckrodt Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Description and Business Overview
Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2020)
Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales Market Share in Global Market
Table GE Healthcare Recent Development
Table Lantheus Medical Imaging Company Details
Table Lantheus Medical Imaging Description and Business Overview
Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2020)
Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2020)
Table Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales Market Share in Global Market
Table Lantheus Medical Imaging Recent Development
Table Bayer Healthcare Company Details
Table Bracco Imaging Company Details
Table Eczacibasi-Monrol Nuclear Products Company Details
Table Nordion Company Details
Table Advanced Accelerator Applications Company Details
Table Iba Molecular Imaging Company Details
Figure Nuclear Medicine/Radiopharmaceutic Value Chain
Table Nuclear Medicine/Radiopharmaceutic Distributors List
Table Nuclear Medicine/Radiopharmaceutic Customers List
Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast 2020-2027(MT) & (Million US$)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Forecast 2020-2027(MT)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast 2020-2027(Million US$)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type 2020-2027(MT)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type 2020-2027(MT)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Type 2020-2025
Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application 2020-2027(MT)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application 2020-2027(MT)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Application 2020-2025
Table Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions 2020-2027(MT)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions 2020-2027(MT)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Regions 2020-2025
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Regions 2020-2027(MT)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Regions 2020-2027(MT)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Regions 2020-2025
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Forecast 2020-2027(MT)
Figure United States Nuclear Medicine/Radiopharmaceutic Revenue Forecast 2020-2027(Million US$)
Figure European Union Nuclear Medicine/Radiopharmaceutic Sales Forecast 2020-2027(MT)
Figure European Union Nuclear Medicine/Radiopharmaceutic Revenue Forecast 2020-2027(Million US$)
Figure China Nuclear Medicine/Radiopharmaceutic Sales Forecast 2020-2027(MT)
Figure China Nuclear Medicine/Radiopharmaceutic Revenue Forecast 2020-2027(Million US$)
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Forecast 2020-2027(MT)
Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue Forecast 2020-2027(Million US$)
Figure Korea Nuclear Medicine/Radiopharmaceutic Sales Forecast 2020-2027(MT)
Figure Korea Nuclear Medicine/Radiopharmaceutic Revenue Forecast 2020-2027(Million US$)
Figure India Nuclear Medicine/Radiopharmaceutic Sales Forecast 2020-2027(MT)
Figure India Nuclear Medicine/Radiopharmaceutic Revenue Forecast 2020-2027(Million US$)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Forecast 2020-2027(MT)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue Forecast 2020-2027(Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources